American Express Company (FRA:AEC1)
Germany · Delayed Price · Currency is EUR 253.75
-11.30 (-4.26%)
At close: Aug 1, 2025, 10:00 PM CET
CTI BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 10,146 | 10,129 | 8,374 | 7,514 | 8,060 | 3,135 | Upgrade |
Depreciation & Amortization | 1,725 | 1,676 | 1,651 | 1,626 | 1,695 | 1,543 | Upgrade |
Provision for Credit Losses | 5,203 | 5,185 | 4,923 | 2,182 | -1,419 | 4,730 | Upgrade |
Stock-Based Compensation | 509 | 504 | 450 | 375 | 330 | 249 | Upgrade |
Net Decrease (Increase) in Loans Originated / Sold - Operating | - | - | 5 | - | - | - | Upgrade |
Change in Accounts Payable | -3,575 | -2,897 | 5,065 | 8,815 | 5,389 | -2,025 | Upgrade |
Change in Other Net Operating Assets | -208 | 1,007 | -1,244 | 1,391 | 1,068 | -1,785 | Upgrade |
Other Operating Activities | -706 | -1,554 | -665 | -824 | -478 | -256 | Upgrade |
Operating Cash Flow | 13,094 | 14,050 | 18,559 | 21,079 | 14,645 | 5,591 | Upgrade |
Operating Cash Flow Growth | -47.83% | -24.30% | -11.96% | 43.93% | 161.94% | -58.99% | Upgrade |
Capital Expenditures | -2,003 | -1,917 | -1,565 | -1,856 | -1,638 | -1,479 | Upgrade |
Sale of Property, Plant & Equipment | 4 | 6 | 2 | 1 | 88 | 1 | Upgrade |
Cash Acquisitions | -1,087 | -454 | -64 | -15 | - | -597 | Upgrade |
Divestitures | 10 | 594 | - | - | 1 | - | Upgrade |
Investment in Securities | -356 | 628 | 2,318 | -2,257 | 18,577 | -13,334 | Upgrade |
Net Decrease (Increase) in Loans Originated / Sold - Investing | -18,681 | -23,259 | -25,124 | -29,562 | -27,557 | 26,906 | Upgrade |
Other Investing Activities | - | - | - | - | - | 135 | Upgrade |
Investing Cash Flow | -22,113 | -24,402 | -24,433 | -33,689 | -10,529 | 11,632 | Upgrade |
Short-Term Debt Issued | - | 207 | - | - | 461 | - | Upgrade |
Long-Term Debt Issued | - | 12,602 | 15,674 | 23,230 | 7,788 | 69 | Upgrade |
Total Debt Issued | 20,368 | 12,809 | 15,674 | 23,230 | 8,249 | 69 | Upgrade |
Short-Term Debt Repaid | - | - | -105 | -706 | - | -4,627 | Upgrade |
Long-Term Debt Repaid | - | -10,759 | -10,703 | -18,906 | -11,662 | -15,593 | Upgrade |
Total Debt Repaid | -14,503 | -10,759 | -10,808 | -19,612 | -11,662 | -20,220 | Upgrade |
Net Debt Issued (Repaid) | 5,865 | 2,050 | 4,866 | 3,618 | -3,413 | -20,151 | Upgrade |
Issuance of Preferred Stock | - | - | - | - | 1,584 | - | Upgrade |
Preferred Share Repurchases | - | - | - | - | -1,600 | - | Upgrade |
Issuance of Common Stock | 76 | 100 | 28 | 56 | 64 | 44 | Upgrade |
Repurchase of Common Stock | -5,530 | -6,020 | -3,650 | -3,502 | -7,652 | -1,029 | Upgrade |
Common Dividends Paid | -1,999 | -1,999 | - | - | - | - | Upgrade |
Total Dividends Paid | -2,128 | -1,999 | -1,780 | -1,565 | -1,448 | -1,474 | Upgrade |
Other Financing Activities | 15,618 | 10,305 | 18,915 | 25,902 | -2,468 | 13,542 | Upgrade |
Financing Cash Flow | 13,901 | 4,436 | 18,379 | 24,509 | -14,933 | -9,068 | Upgrade |
Foreign Exchange Rate Adjustments | 160 | -40 | 177 | -13 | -120 | 364 | Upgrade |
Net Cash Flow | 5,042 | -5,956 | 12,682 | 11,886 | -10,937 | 8,519 | Upgrade |
Free Cash Flow | 11,091 | 12,133 | 16,994 | 19,223 | 13,007 | 4,112 | Upgrade |
Free Cash Flow Growth | -52.41% | -28.60% | -11.59% | 47.79% | 216.32% | -65.57% | Upgrade |
Free Cash Flow Margin | 17.48% | 19.97% | 30.57% | 37.93% | 29.70% | 13.11% | Upgrade |
Free Cash Flow Per Share | 15.75 | 17.02 | 23.09 | 25.56 | 16.46 | 5.10 | Upgrade |
Cash Interest Paid | 8,200 | 8,200 | 6,400 | 2,200 | 1,100 | 2,000 | Upgrade |
Cash Income Tax Paid | 3,600 | 3,600 | 3,300 | 3,000 | 1,600 | 2,200 | Upgrade |
Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.